Cargando…

YouTube as a source of information on COVID-19 vaccination in rheumatic diseases

As the most well-known and popular video-sharing platform around the world, YouTube is an influential tool for the dissemination of health-related information. In addition, considering the increase in obtaining information from internet-based sources in pandemic conditions, YouTube has become more i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kocyigit, Burhan Fatih, Akyol, Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475344/
https://www.ncbi.nlm.nih.gov/pubmed/34562126
http://dx.doi.org/10.1007/s00296-021-05010-2
_version_ 1784575408941826048
author Kocyigit, Burhan Fatih
Akyol, Ahmet
author_facet Kocyigit, Burhan Fatih
Akyol, Ahmet
author_sort Kocyigit, Burhan Fatih
collection PubMed
description As the most well-known and popular video-sharing platform around the world, YouTube is an influential tool for the dissemination of health-related information. In addition, considering the increase in obtaining information from internet-based sources in pandemic conditions, YouTube has become more important in the presentation of information related to COVID-19. Therefore, the aim of this study was to evaluate videos related to COVID-19 vaccination in rheumatic diseases (RD) on YouTube. In this descriptive study, 334 video URLs listed with six search terms were recorded (26 July 2021). Three quality groups (high, intermediate, and low) were created based on the Global Quality Scores (GQS). Video sources were identified and various video parameters were compared between the quality groups. Following the implementation of the exclusion criteria, 56 videos remained for further analysis; of which 37 (66.07%) were evaluated as high quality, 12 (21.42%) as intermediate quality, and 7 (12.51%) as low quality. No significant difference was determined between the quality groups in per day values of views, likes, dislikes, and comments. The sources of high-quality videos were pharmaceutical company (n = 1; 100%), pharmacist (n = 1; 100%), society-organization (n = 17; 85%), and academic (n = 3; 75%). Although two-thirds of the videos were high quality, it should be kept in mind that intermediate and low-quality videos are also available. Users should not assume the quality of the videos based on the number of views, likes, dislikes, and comments, but should focus more on video sources.
format Online
Article
Text
id pubmed-8475344
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-84753442021-09-28 YouTube as a source of information on COVID-19 vaccination in rheumatic diseases Kocyigit, Burhan Fatih Akyol, Ahmet Rheumatol Int Observational Research As the most well-known and popular video-sharing platform around the world, YouTube is an influential tool for the dissemination of health-related information. In addition, considering the increase in obtaining information from internet-based sources in pandemic conditions, YouTube has become more important in the presentation of information related to COVID-19. Therefore, the aim of this study was to evaluate videos related to COVID-19 vaccination in rheumatic diseases (RD) on YouTube. In this descriptive study, 334 video URLs listed with six search terms were recorded (26 July 2021). Three quality groups (high, intermediate, and low) were created based on the Global Quality Scores (GQS). Video sources were identified and various video parameters were compared between the quality groups. Following the implementation of the exclusion criteria, 56 videos remained for further analysis; of which 37 (66.07%) were evaluated as high quality, 12 (21.42%) as intermediate quality, and 7 (12.51%) as low quality. No significant difference was determined between the quality groups in per day values of views, likes, dislikes, and comments. The sources of high-quality videos were pharmaceutical company (n = 1; 100%), pharmacist (n = 1; 100%), society-organization (n = 17; 85%), and academic (n = 3; 75%). Although two-thirds of the videos were high quality, it should be kept in mind that intermediate and low-quality videos are also available. Users should not assume the quality of the videos based on the number of views, likes, dislikes, and comments, but should focus more on video sources. Springer Berlin Heidelberg 2021-09-25 2021 /pmc/articles/PMC8475344/ /pubmed/34562126 http://dx.doi.org/10.1007/s00296-021-05010-2 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Observational Research
Kocyigit, Burhan Fatih
Akyol, Ahmet
YouTube as a source of information on COVID-19 vaccination in rheumatic diseases
title YouTube as a source of information on COVID-19 vaccination in rheumatic diseases
title_full YouTube as a source of information on COVID-19 vaccination in rheumatic diseases
title_fullStr YouTube as a source of information on COVID-19 vaccination in rheumatic diseases
title_full_unstemmed YouTube as a source of information on COVID-19 vaccination in rheumatic diseases
title_short YouTube as a source of information on COVID-19 vaccination in rheumatic diseases
title_sort youtube as a source of information on covid-19 vaccination in rheumatic diseases
topic Observational Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475344/
https://www.ncbi.nlm.nih.gov/pubmed/34562126
http://dx.doi.org/10.1007/s00296-021-05010-2
work_keys_str_mv AT kocyigitburhanfatih youtubeasasourceofinformationoncovid19vaccinationinrheumaticdiseases
AT akyolahmet youtubeasasourceofinformationoncovid19vaccinationinrheumaticdiseases